Status:
COMPLETED
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Non-Hodgkins Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
Patients with aggressive Non-Hodgkin-lymphoma treated at first diagnosis with chemotherapy alone or combined chemo-radiotherapy can achieve high response rates. However, patients with relapsed lymphom...
Eligibility Criteria
Inclusion
- \- a) Age over 18 b) Patients with Non-Hodgkin's Lymphoma who have received an autologous stem cell transplant in the past.
- c) Informed written consent
Exclusion
- a) Medical or psychiatric conditions that compromise the patient's ability to give informed consent b) HIV positive or AIDS related lymphoma
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00301288
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS trust
Sutton, Surrey, United Kingdom, SM2 5PT